152 related articles for article (PubMed ID: 25809027)
1. Lu/BCAM-mediated cell adhesion as biological marker of JAK2V617F activity in erythrocytes of polycythemia vera patients.
De Grandis M; Cassinat B; Kiladjian JJ; Chomienne C; El Nemer W
Am J Hematol; 2015 Jul; 90(7):E137-8. PubMed ID: 25809027
[No Abstract] [Full Text] [Related]
2. JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway.
De Grandis M; Cambot M; Wautier MP; Cassinat B; Chomienne C; Colin Y; Wautier JL; Le Van Kim C; El Nemer W
Blood; 2013 Jan; 121(4):658-65. PubMed ID: 23160466
[TBL] [Abstract][Full Text] [Related]
3. Impact of hydroxycarbamide and interferon-α on red cell adhesion and membrane protein expression in polycythemia vera.
Brusson M; De Grandis M; Cochet S; Bigot S; Marin M; Leduc M; Guillonneau F; Mayeux P; Peyrard T; Chomienne C; Le Van Kim C; Cassinat B; Kiladjian JJ; El Nemer W
Haematologica; 2018 Jun; 103(6):972-981. PubMed ID: 29599206
[TBL] [Abstract][Full Text] [Related]
4. Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM.
Wautier MP; El Nemer W; Gane P; Rain JD; Cartron JP; Colin Y; Le Van Kim C; Wautier JL
Blood; 2007 Aug; 110(3):894-901. PubMed ID: 17412890
[TBL] [Abstract][Full Text] [Related]
5. Lutheran.
Daniels G
Immunohematology; 2009; 25(4):152-9. PubMed ID: 20406022
[TBL] [Abstract][Full Text] [Related]
6. Erythrocytes from patients with myeloproliferative neoplasms and splanchnic venous thrombosis show greater expression of Lu/BCAM.
Novitzky-Basso I; Spring F; Anstee D; Tripathi D; Chen F
Int J Lab Hematol; 2018 Aug; 40(4):473-477. PubMed ID: 29756283
[TBL] [Abstract][Full Text] [Related]
7. Red cell and endothelial Lu/BCAM beyond sickle cell disease.
Colin Y; Rahuel C; Wautier MP; El Nemer W; Filipe A; Cartron JP; Le Van Kim C; Wautier JL
Transfus Clin Biol; 2008 Dec; 15(6):402-5. PubMed ID: 18948049
[TBL] [Abstract][Full Text] [Related]
8. [Vascular myeloproliferative neoplasm with normal cell blood count: Exploration and medical management].
Fourgeaud C; El Nemer W; Michon Pasturel U; Bonhomme S; Brignier A; Lazareth I; Priollet P
J Mal Vasc; 2015 Dec; 40(6):350-8. PubMed ID: 26362408
[TBL] [Abstract][Full Text] [Related]
9. Role of Lu/BCAM glycoproteins in red cell diseases.
El Nemer W; Colin Y; Le Van Kim C
Transfus Clin Biol; 2010 Sep; 17(3):143-7. PubMed ID: 20655789
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera.
Tefferi A; Strand JJ; Lasho TL; Knudson RA; Finke CM; Gangat N; Pardanani A; Hanson CA; Ketterling RP
Leukemia; 2007 Sep; 21(9):2074-5. PubMed ID: 17476276
[No Abstract] [Full Text] [Related]
11. The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.
Chang HY; Chang HM; Wu TJ; Chaing CY; Tzai TS; Cheng HL; Raghavaraju G; Chow NH; Liu HS
J Biomed Sci; 2017 Aug; 24(1):61. PubMed ID: 28841878
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
Rossi D; Cortini F; Deambrogi C; Barbieri C; Cerri M; Franceschetti S; Conconi A; Capello D; Gaidano G
Leuk Res; 2007 Jan; 31(1):97-101. PubMed ID: 16620973
[TBL] [Abstract][Full Text] [Related]
13. Abnormal adhesion of red blood cells in polycythemia vera: a prothrombotic effect?
El Nemer W; De Grandis M; Brusson M
Thromb Res; 2014 May; 133 Suppl 2():S107-11. PubMed ID: 24862129
[TBL] [Abstract][Full Text] [Related]
14. Role of the interaction between Lu/BCAM and the spectrin-based membrane skeleton in the increased adhesion of hereditary spherocytosis red cells to laminin.
Gauthier E; El Nemer W; Wautier MP; Renaud O; Tchernia G; Delaunay J; Le Van Kim C; Colin Y
Br J Haematol; 2010 Feb; 148(3):456-65. PubMed ID: 20092464
[TBL] [Abstract][Full Text] [Related]
15. JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?
Verstovsek S; Silver RT; Cross NC; Tefferi A
Leukemia; 2006 Nov; 20(11):2067. PubMed ID: 16990780
[No Abstract] [Full Text] [Related]
16. Novel role for the Lu/BCAM-spectrin interaction in actin cytoskeleton reorganization.
Collec E; Lecomte MC; El Nemer W; Colin Y; Le Van Kim C
Biochem J; 2011 Jun; 436(3):699-708. PubMed ID: 21434869
[TBL] [Abstract][Full Text] [Related]
17. JAK2V617F mutation in a 9-year-old girl with polycythemia vera and Budd-Chiari syndrome: a case report.
Benedik-Dolničar M; Homan M; Brecelj J
J Pediatr Hematol Oncol; 2012 Apr; 34(3):243-4. PubMed ID: 21552144
[No Abstract] [Full Text] [Related]
18. A resequencing program in India detects the rare JAK2 L579F mutation in patients suffering from polycythemia vera and negative for JAK2 V617F.
Acharya A; Vaniawala S; Parekh H; Sheikh H; Patel H; Ali R; Khan A; Nagee A; Kunjadia P; Mukhopadhyaya PN
Int J Lab Hematol; 2014 Aug; 36(4):e30-3. PubMed ID: 24033912
[No Abstract] [Full Text] [Related]
19. JAK2V617F allele burden in patients with myeloproliferative neoplasms.
Alshemmari SH; Rajaan R; Ameen R; Al-Drees MA; Almosailleakh MR
Ann Hematol; 2014 May; 93(5):791-6. PubMed ID: 24362471
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera.
Lanikova L; Babosova O; Swierczek S; Wang L; Wheeler DA; Divoky V; Korinek V; Prchal JT
Blood; 2016 Nov; 128(18):2266-2270. PubMed ID: 27647865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
